EMED Electromedical Technologies, Inc OTC · United States

Electromedical Technologies (EMED) news

Electromedical Technologies, Inc is a public biotech or pharmaceutical company listed on OTC under the ticker EMED, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Electromedical Technologies news

We have not published a story on Electromedical Technologies yet. When there is news, it will appear here.

Electromedical Technologies annual financials

Line	FY2023	FY2022
Revenue	$1.3 million	$1.1 million
Research and development	$231,434	$92,299
Net income (loss)	-$2.6 million	-$3.5 million
Cash from operations	-$1.4 million	-$773,337
Cash and equivalents	$87,704	$368,425

Latest balance sheet, Sep 30, 2024 (10-Q): cash and equivalents $34,809.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Electromedical Technologies

What is the ticker symbol of Electromedical Technologies?

Electromedical Technologies, Inc trades under the ticker EMED on OTC.

Where is Electromedical Technologies listed?

Electromedical Technologies, Inc is listed on OTC.

Which country or territory is Electromedical Technologies listed under?

Our directory records Electromedical Technologies, Inc under United States.

Does aibio.space cover Electromedical Technologies?

aibio.space lists Electromedical Technologies, Inc among 2,820 public biotech companies and publishes its news here as stories appear.

What was Electromedical Technologies's revenue last year?

$1.3 million for the fiscal year ended Dec 31, 2023, as reported to the SEC.

Is Electromedical Technologies profitable?

Electromedical Technologies, Inc reported a net loss of $2.6 million for the fiscal year ended Dec 31, 2023, and used $1.4 million of cash in operations, per its annual report to the SEC.

How much does Electromedical Technologies spend on research and development?

$231,434 in the fiscal year ended Dec 31, 2023, per its annual report.

How much cash does Electromedical Technologies have?

$34,809 in cash at Sep 30, 2024, per its 10-Q.

Investor discussion: Electromedical Technologies

Members talk about Electromedical Technologies (EMED). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:EMED on TradingView.

Listing details

Company: Electromedical Technologies, Inc
Ticker: EMED
Listing: OTC
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction